VUM02 Injection
Idiopathic Pulmonary Fibrosis · China Registry
Clinical trials
1
Mechanism
China Registry
Developer
Wuhan Optics Valley Vcanbiopharma Co., Ltd.
Overview
VUM02 Injection is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis, acting via china registry. It appears in 1 tracked IPF clinical trial.
VUM02 Injection clinical trials
Explore related
Medical disclaimer. This page summarizes research about VUM02 Injection for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.